Impact of Nonspecific Antipidemic Measures against COVID-19 on the INCIDENCE of Acute Purulent Meningitis during the Pandemic
https://doi.org/10.31631/2073-3046-2022-21-3-117-120
Abstract
Relevance. Nonspecific anti-epidemic measures against СOVID-19 (mask-wearing, social distancing, lockdowns, homework, quarantines, school closures, tourism bans, etc.) resulted in a significant decrease in the incidence of many respiratory infections. Scientific publications have reported a decrease in the incidence of bacterial purulent meningitis (BMP) during the development of the COVID-19 pandemic. Aims. To review the scientific publications on the decline in the incidence of BMP during the СOVID-19 pandemic. Conclusions. Undoubtedly non-specific anti-epidemic measures taken during the COVID-19 pandemic helped to reduce the incidence of respiratory infections regardless of their etiology and could serve as an indirect indicator of the activity of these measures.
About the Authors
N. N. Kostyukova
The National Research Center for Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya
Russian Federation
Russian Federation
Natalya N. Kostyukova – Dr. Sci. (Med.), Professor, Leading Researcher
Moscow
+7 (499) 193-61-51, +7 (499) 249-69-24
V. A Bekhalo
The National Research Center for Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya
Russian Federation
Russian Federation
Vladimir A. Behalo – Cand. Sci. (Med.), Leading Researcher
Moscow
+ 7(916)935 41 42
References
1. Brueggemann A.B., van Rensberg M.J.J., Shaw D., et al. Changes of the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive Respiratory Surveillance Initiatives: a prospective analysis of surveillance data. Lancet Digit Health, 2021 3:e360–370.
2. Kadambari S., Goldacre R., Morris E., et al. Indirect effectiveness of the covid-19 pandemic on childhood infection in England: population based observation study. BMJ. 2022;376: e067519.
3. Anderson M.R., Arkwright P.D., Bai X., et al. Surveillance and control of meningococcal disease in the COVID-19 era: a Global Meningococcal Initiative review. J. Infection, 2022,84:289–296.
4. Subbarao S., Campbell H., Ribeiro S. et al. Invasive meningococcal disease, 2011-2020, and impact of COVID-19 pandemic, England. Emerg. Infect. Dis., 2021;27( 9):2495–2497.
5. Ladhani S.N., Andrew S. N., Rarikh S.R., et al. Vaccination of infants with meningococcal group B vaccine (4CMenB) in England. N.Engl. Med. J. 2020;382:309–317.
6. Clark A., Campbell H., Mensah A.A., et al. An increase in group B invasive meningococcal infection disease among adolescents and young adults in England following easing of COVID-19 containment measures. Preprint. SSRN:https://ssrn.com/abstract=3998164
7. McMillan M., Walters L., Sullivan T., et al. Impact of meningococcal B (4CMenB) vaccine on pharyngeal Neisseria meningitidis carriage density and persistence in adolescents. Clin. Infect. Dis. 2021;73 (1):e99–106.
8. Taha M.Kh., Deghmane A.E. Impact of COVID-19 pandemic and the lock-down on invasive meningococcal disease. BMC Res. Notes. 2020;13:399.
9. Ktena D.,Kourkouni E., Kontopidou S., et al. Population based of influenza and invasive meningococcal disease among Greek children during the COVID-19 pandemic. BMJ Paeditrics Open. 2022;6:e001391.
10. George C.R.R., Booy R., Nissen M.D., Lahra M.U. The decline of invasive meningococcal disease and influenza in the time of COVID-19 : the silver linings of the pandemic playbook. Med. J. Aust. Mar 27. doi: 10.5694/mja2.51463. Epub ahead of print. PMID: 35340025
11. Kim.J.K., Choi Y.Y., Lee H., et al. Differential impact of non-pharmaceutical interventions on the epidemiology of invasive meningococcal infections in children during the coronavirus disease 2019 pandemic. Pediat. Infect. Dis. J. 2022;41:91–96.
12. Willen L., Ekinci E., Cuipers L., et al. Infant pneumococcal carriage in Belgium not affected by COVID-19 containment measures. Frontiers in Cell. Infect. Microbiol. 2022;11:825427.
13. Dirkx K.K.T., Mulder B., Post S.A., et al. The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained. Intern. J. Infect. Dis. 2021:11196–203.
14. Casanova C., Kuiffer M., Leib St.L., Helty M. Re-emergence of invasive pneumococcal disease (IPD) and increase of serotype 23B after easing of COVID-19 measures, Switzerland, 2021. Emerging Microb. Infect., 2021, Dec.10(1):2202–2204.
15. Koroleva M.A., Koroleva I.S., Gritsay M.I. Etiologic structure of purulent bacterial meningitis in Russian Federation. J.Infectiology. 2022;1, Suppl.:20 (in Russ,).
16. Koroleva M.A., Mironov K.O., Koroleva I.S. Epidemiologocal characteristics of generilized meningococcal infection caused by Neisseria meningitidis serogroup W in the world and in Russian Fedderation. Epidemiology and Vaccine Prevention (in Russ.), 2018, 3:16-23
17. Baker R.E., Park S.W., Yang W., et al. The impact of COVID-19 non-pharmaceutical interventions on the future dynamics of endemic infections. PNAS. 2920;117(48):30547–30553.
18. Binns E., Koenraads L., Hristeva L., et al. Influenza and respiratory syntycial virus during COVID-19 pandemic: time for new paradigm? Pediatric Pulmonology. 2022;57(1):38–42.
19. Groves H.E., Piche-Renaud P.-Ph., Peci A., et al. The impact of COVID-19 pandemic on influenza, respiratory syntycial virus, and other seasonal respiratory virus circulation in Canada: a population-based study. The Lancet Regional Health – Americas. 2021;1:100015.
20. Ippolito G., LaVecchia A., Umbrello G., et al. Disappearance of seasonal respiratory viruses in children under two years old during COVID-19 pandemic: a monocentric retrospective study in Milan. Italy. Frontiers in Pediatrics. 2021;9:721005.
21. Sominina A.A., Danilenko D.V., Stolyarov K.A., Karpova L.S., Bakaev M.I., Levanyuk T.R. et al. Interference of SARS-CoV-2 with the respiratory viral infection agents during pandemic. Epidemiology and Vaccinal Prevention. 2021;4:28–39 (in Russ.).
Review
For citations:
Kostyukova N.N., Bekhalo V.A. Impact of Nonspecific Antipidemic Measures against COVID-19 on the INCIDENCE of Acute Purulent Meningitis during the Pandemic. Epidemiology and Vaccinal Prevention. 2022;21(3):117-120. (In Russ.) https://doi.org/10.31631/2073-3046-2022-21-3-117-120
Views:
450
Email this article 